BRODNEY MICHAEL AARON,DAVOREN JENNIFER ELIZABETH,DOUNAY AMY BETH,EFREMOV IVAN VIKTOROVICH,GRAY DAVID LAWRENCE FIRMAN,GREEN MICHAEL ERIC,HENDERSON JACLYN LOUISE,LEE CHEWAH,MENTE SCOT RICHARD,ONEIL STEV
申请号：
IN201617000997
公开号：
IN201617000997A
申请日:
2016.01.11
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention provides in part compounds of Formula (I) and pharmaceutically acceptable salts thereof processes for the preparation of intermediates used in the preparation of and compositions containing such compounds or salts and their uses for treating D1 mediated (or D1 associated) disorders including e.g. schizophrenia (e.g. its cognitive and negative symptoms) cognitive impairment (e.g. cognitive impairment associated with schizophrenia AD PD or pharmacotherapy therapy) age related cognitive decline dementia and Parkinson s disease.
